Clinical Trial Update: A Study of Adebrelimab in Combination With Apatinib Gemcitabine and Cisplatin in Biliary Tract Malignancies [Phase 1]

View source ↗

Summary

This clinical trial update reports a Phase 1 study evaluating the combination of adebrelimab with apatinib, gemcitabine, and cisplatin in biliary tract malignan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• Apatinib (apatinib)
• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: First Affiliated Hospital of Fujian Medical University | Conditions: Biliary Tract Malignancies | Phase 1 | Status: RECRUITING